Study Finds Divergent Views on Medical Cannabis Between Cancer Survivors and Providers

Medical cannabis has become a common tool for many cancer survivors seeking relief from pain, nausea, and anxiety, reflecting the drug’s expanding role in symptom management. With legal access now available in 47 states, Washington, D.C., and three U.S. territories, the use of medical cannabis continues to rise among both the general public and those battling cancer.

Despite its growing popularity, research on how survivors and their health‑care providers perceive medical cannabis remains sparse. Studies suggest a gap in knowledge about patients’ attitudes toward the treatment and a lack of comfort among clinicians in discussing its use. This uncertainty can hinder effective communication and decision‑making about complementary therapies in oncology settings.

Addressing this knowledge gap is essential for improving patient care. As medical cannabis becomes more integrated into cancer treatment plans, better understanding of both patient and provider perspectives will help ensure that discussions about its benefits, risks, and appropriate use are informed, evidence‑based, and aligned with each survivor’s preferences.